Skip to main content
SpringerLink
Log in

Hypertension and Age-Related Cognitive Decline

  • Chapter
  • First Online:
Hypertension and the Brain as an End-Organ Target

Abstract

As the population is aging rapidly worldwide, there is an increasing need to better understand chronic conditions associated with aging such as vascular and metabolic diseases, and cognitive decline. Hypertension is one of the most prevalent chronic conditions associated with age and its impact on cognitive decline has often been put forth. Overall, both longitudinal and cross-sectional investigations suggest that hypertension can increase the risk of cognitive decline, and that the negative impact is more salient in processing speed and executive control tests. However, memory deficits associated with hypertension can also be observed. While hypertension has consistently been shown to increase the risk of dementia in middle-aged or young-old adults, some studies suggest that it could have a protective effect on cognition in very old populations. Studies looking at the effect of antihypertensive drug treatments report diverging results, but tend to suggest that treatment might be effective in preventing cognitive decline associated with age. Together, findings summarized here suggest that hypertension is an important factor that has a worsening effect on cognition as people age, and that antihypertensive approaches could help control or alleviate the impact of elevated blood pressure on cognition. Future studies will help identify effective ways to control hypertension and potentially emphasize preventive approaches as complementary avenues to the more traditional pharmacological approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Baltes PB, Staudinger UM, Lindenberger U. Lifespan psychology: theory and application to intellectual functioning. Annu Rev Psychol. 1999;50:471–507.

    Article  CAS  PubMed  Google Scholar 

  2. Park DC, Gutchess AH. Aging, cognition, and culture: a neuroscientific perspective. Neurosci Biobehav Rev. 2002;26(7):859–67.

    Article  PubMed  Google Scholar 

  3. Bherer L, Belleville S, Hudon C. Le déclin des fonctions exécutives au cours du vieillissement normal, dans la maladie d’Alzheimer et dans la démence frontotemporale. Psychol Neuropsychiatr Vieil. 2004;2(3):181–9.

    PubMed  Google Scholar 

  4. Miyake A, et al. The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: a latent variable analysis. Cogn Psychol. 2000;41:49–100.

    Article  CAS  PubMed  Google Scholar 

  5. West RL. An application of prefrontal cortex function theory to cognitive aging. Psychol Bull. 1996;120(2):272–92.

    Article  CAS  PubMed  Google Scholar 

  6. Verhaeghen P, Cerella J. Aging, executive control, and attention: a review of meta-analyses. Neurosci Biobehav Rev. 2002;26(7):849–57.

    Article  PubMed  Google Scholar 

  7. den Dunnen WF, et al. No disease in the brain of a 115-year-old woman. Neurobiol Aging. 2008;29(8):1127–32.

    Article  Google Scholar 

  8. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 2004;3(6):343–53.

    Article  PubMed  Google Scholar 

  9. Hertzog C, et al. Enrichment effects on adult cognitive development: can the functional capacity of older adults be preserved and enhanced? Psychol Sci. 2009;9(1):1–65.

    Google Scholar 

  10. Kramer AF, et al. Environmental influences on cognitive and brain plasticity during aging. J Gerontol A Biol Sci Med Sci. 2004;59(9):M940–57.

    Article  PubMed  Google Scholar 

  11. Desjardins-Crepeau L, et al. Physical functioning is associated with processing speed and executive functions in community-dwelling older adults. J Gerontol B Psychol Sci Soc Sci, 2014.

    Google Scholar 

  12. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. J Vasc Health Risk Manag. 2008;4(2):363–81.

    CAS  Google Scholar 

  13. Whitmer RA, et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64(2):277–81.

    Article  CAS  PubMed  Google Scholar 

  14. Gorelick PB. Status of risk factors for dementia associated with stroke. Stroke. 1997;28(2):459–63.

    Article  CAS  PubMed  Google Scholar 

  15. Anstey K, Christensen H. Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: a review. Gerontology. 2000;46(3):163–77.

    Article  CAS  PubMed  Google Scholar 

  16. Elias MF, et al. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham study. Am J Epidemiol. 1993;138(6):353–64.

    CAS  PubMed  Google Scholar 

  17. Kennelly SP, Lawlor BA, Kenny RA. Blood pressure and the risk for dementia: a double edged sword. Ageing Res Rev. 2009;8(2):61–70.

    Article  PubMed  Google Scholar 

  18. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4(8):487–99.

    Article  PubMed  Google Scholar 

  19. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.

    Article  PubMed  Google Scholar 

  20. Petrovitch H, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging. 2000;21(1):57–62.

    Article  CAS  PubMed  Google Scholar 

  21. Breteler MM, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44(7):1246–52.

    Article  CAS  PubMed  Google Scholar 

  22. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.

    Article  CAS  PubMed  Google Scholar 

  23. Cahn-Weiner DA, et al. Prediction of functional status from neuropsychological tests in community-dwelling elderly individuals. Clin Neuropsychol. 2000;14(2):187–95.

    Article  CAS  PubMed  Google Scholar 

  24. Verghese J, et al. Validity of divided attention tasks in predicting falls in older individuals: a preliminary study. J Am Geriatr Soc. 2002;50(9):1572–6.

    Article  PubMed  Google Scholar 

  25. Grigsby J, et al. Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study. J Am Geriatr Soc. 1998;46(5):590–6.

    Article  CAS  PubMed  Google Scholar 

  26. Blacker D, et al. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol. 2007;64(6):862–71.

    Article  PubMed  Google Scholar 

  27. Tzourio C, et al. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA study group. Epidemiology of vascular aging. Neurology. 1999;53(9):1948–52.

    Article  CAS  PubMed  Google Scholar 

  28. de Alves Moraes S. The relationship between temporal changes in blood pressure and changes in cognitive function: atherosclerosis risk in communities (ARIC) study. Prev Med. 2002;35(3):258–63.

    Article  Google Scholar 

  29. Knopman D, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56(1):42–8.

    Article  CAS  PubMed  Google Scholar 

  30. Kilander L, et al. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 1998;31(3):780–6.

    Article  CAS  PubMed  Google Scholar 

  31. Kuo HK, et al. Effect of blood pressure and diabetes mellitus on cognitive and physical functions in older adults: a longitudinal analysis of the advanced cognitive training for independent and vital elderly cohort. J Am Geriatr Soc. 2005;53(7):1154–61.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Swan GE, Carmelli D, Larue A. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke. 1998;29(11):2334–40.

    Article  CAS  PubMed  Google Scholar 

  33. Weisenbach SL, Boore LA, Kales HC. Depression and cognitive impairment in older adults. Curr Psychiatry Rep. 2012;14(4):280–8.

    Article  PubMed  Google Scholar 

  34. Singh-Manoux A, et al. History of coronary heart disease and cognitive performance in midlife: the Whitehall II study. Eur Heart J. 2008;29(17):2100–7.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Glynn RJ, et al. Current and remote blood pressure and cognitive decline. JAMA. 1999;281(5):438–45.

    Article  CAS  PubMed  Google Scholar 

  36. Waldstein SR, et al. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension. 2005;45(3):374–9.

    Article  CAS  PubMed  Google Scholar 

  37. Morris MC, et al. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology. 2002;21(3):123–30.

    Article  PubMed  Google Scholar 

  38. Hebert LE, et al. Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology. 2004;62(11):2021–4.

    Article  CAS  PubMed  Google Scholar 

  39. Tsivgoulis G, et al. Association of higher diastolic blood pressure levels with cognitive impairment. Neurology. 2009;73(8):589–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Robbins MA, et al. Blood pressure and cognitive function in an African-American and a Caucasian-American sample: the Maine-Syracuse Study. Psychosom Med. 2005;67(5):707–14.

    Article  PubMed  Google Scholar 

  41. Vicario A, et al. Hypertension and cognitive decline: impact on executive function. J Clin Hypertens (Greenwich). 2005;7(10):598–604.

    Article  Google Scholar 

  42. Saxby BK, et al. Effects of hypertension on attention, memory, and executive function in older adults. Health Psychol. 2003;22(6):587–91.

    Article  PubMed  Google Scholar 

  43. Di Carlo A, et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc. 2000;48(7):775–82.

    Article  PubMed  Google Scholar 

  44. van Boxtel MP, et al. Can the blood pressure predict cognitive task performance in a healthy population sample? J Hypertens. 1997;15(10):1069–76.

    Article  PubMed  Google Scholar 

  45. Brady CB, Spiro 3rd A, Gaziano JM. Effects of age and hypertension status on cognition: the Veterans Affairs Normative Aging Study. Neuropsychology. 2005;19(6):770–7.

    Article  PubMed  Google Scholar 

  46. Bucur B, Madden DJ. Effects of adult age and blood pressure on executive function and speed of processing. Exp Aging Res. 2010;36(2):153–68.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Elias PK, et al. Blood pressure-related cognitive decline: does age make a difference? Hypertension. 2004;44(5):631–6.

    Article  CAS  PubMed  Google Scholar 

  48. Suhr JA, Stewart JC, France CR. The relationship between blood pressure and cognitive performance in the Third National Health and Nutrition Examination Survey (NHANES III). Psychosom Med. 2004;66(3):291–7.

    PubMed  Google Scholar 

  49. Euser SM, et al. The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc. 2009;57(7):1232–7.

    Article  PubMed  Google Scholar 

  50. Obisesan TO, et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2008;56(3):501–9.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Li G, et al. Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study. J Am Geriatr Soc. 2007;55(8):1161–7.

    Article  PubMed  Google Scholar 

  52. Verghese J, et al. Low blood pressure and the risk of dementia in very old individuals. Neurology. 2003;61(12):1667–72.

    Article  CAS  PubMed  Google Scholar 

  53. Qiu C, et al. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol. 2003;60(2):223–8.

    Article  PubMed  Google Scholar 

  54. Paran E, Anson O, Reuveni H. Blood pressure and cognitive functioning among independent elderly. Am J Hypertens. 2003;16(10):818–26.

    Article  PubMed  Google Scholar 

  55. Guo Z, et al. Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol. 1997;145(12):1106–13.

    Article  CAS  PubMed  Google Scholar 

  56. Sabayan B, et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus Study. J Am Geriatr Soc. 2012;60(11):2014–9.

    PubMed  Google Scholar 

  57. de la Torre JC. Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease. Alzheimer Dis Assoc Disord. 2000;14 Suppl 1:S72–81.

    Article  PubMed  Google Scholar 

  58. Briasoulis A, et al. Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies. Heart. 2014;100(4):317–23.

    Article  CAS  PubMed  Google Scholar 

  59. Launer LJ, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21(1):49–55.

    Article  CAS  PubMed  Google Scholar 

  60. Peila R, et al. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke. 2006;37(5):1165–70.

    Article  PubMed  Google Scholar 

  61. Brust JC. Antihypertensive therapy and cognition: more questions than answers. Stroke. 2006;37(5):1146.

    Article  PubMed  Google Scholar 

  62. in’t Veld BA, et al. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001;22(3):407–12.

    Article  PubMed  Google Scholar 

  63. Dufouil C, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology. 2001;56(7):921–6.

    Article  CAS  PubMed  Google Scholar 

  64. Khachaturian AS, et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006;63(5):686–92.

    Article  PubMed  Google Scholar 

  65. Hajjar I, et al. Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol A Biol Sci Med Sci. 2005;60(1):67–73.

    Article  PubMed  Google Scholar 

  66. Yasar S, et al. Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging. Neurobiol Aging. 2005;26(2):157–63.

    Article  CAS  PubMed  Google Scholar 

  67. Prince MJ, et al. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council’s trial of hypertension in older adults. BMJ. 1996;312(7034):801–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Forette F, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352(9137):1347–51.

    Article  CAS  PubMed  Google Scholar 

  69. Forette F, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002;162(18):2046–52.

    Article  PubMed  Google Scholar 

  70. Lithell H, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21(5):875–86.

    Article  CAS  PubMed  Google Scholar 

  71. Skoog I, et al. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). Am J Hypertens. 2005;18(8):1052–9.

    Article  CAS  PubMed  Google Scholar 

  72. Di Bari M, et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol. 2001;153(1):72–8.

    Article  PubMed  Google Scholar 

  73. Tzourio C, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163(9):1069–75.

    Article  CAS  PubMed  Google Scholar 

  74. McGuinness B, et al. Systematic review: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. J Neurol Neurosurg Psychiatry. 2008;79(1):4–5.

    Article  CAS  PubMed  Google Scholar 

  75. Feigin V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J Neurol Sci. 2005;229–230:151–5.

    Article  PubMed  Google Scholar 

  76. Birns J, et al. The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials. J Hypertens. 2006;24(10):1907–14.

    Article  CAS  PubMed  Google Scholar 

  77. Levi Marpillat N, et al. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens. 2013;31(6):1073–82.

    Article  CAS  PubMed  Google Scholar 

  78. Amenta F, et al. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data. J Neurol Sci. 2002;203–204:147–51.

    Article  PubMed  Google Scholar 

  79. Ohrui T, et al. Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology. 2004;63(7):1324–5.

    Article  CAS  PubMed  Google Scholar 

  80. Hanon O, et al. Prevention of dementia and cerebroprotection with antihypertensive drugs. Curr Hypertens Rep. 2004;6(3):201–7.

    Article  PubMed  Google Scholar 

  81. van Vliet P, et al. Cognitive decline precedes late-life longitudinal changes in vascular risk factors. J Neurol Neurosurg Psychiatry. 2010;81(9):1028–32.

    Article  PubMed  Google Scholar 

  82. Belleville S, Bherer L. Biomarkers of cognitive training effects in aging. Curr Transl Geriatr Exp Gerontol Rep. 2012;1(2):104–10.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Bherer L, Erickson KI, Liu-Ambrose T. A review of the effects of physical activity and exercise on cognitive and brain functions in older adults. J Aging Res. 2013;2013:657508.

    PubMed  PubMed Central  Google Scholar 

  84. van Praag H. Exercise and the brain: something to chew on. Trends Neurosci. 2009;32(5):283–90.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003;14(2):125–30.

    Article  PubMed  Google Scholar 

  86. Whelton SP, et al. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002;136(7):493–503.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

L. Desjardins-Crépeau was supported by a doctoral fellowship from the Canadian Institutes of Health Research and L. Bherer was supported by the Canadian Research Chair Program.

Author information

Authors and Affiliations

  1. Centre de Recherche de l’Institut Universitaire de Gériatrie de Montréal, Chemin Queen-Mary, 4545, Montréal, QC, Canada, H3W 1W5

    Laurence Desjardins-Crépeau & Louis Bherer

  2. Department of Psychology, Université du Québec à Montréal, Succursale Centre-Ville, 8888, Montréal, QC, Canada, H3C 3P8

    Laurence Desjardins-Crépeau

  3. Department of Psychology and PERFORM Centre, Concordia University, Sherbrooke St. W., 7200, Montréal, QC, Canada, H4B 1R6

    Louis Bherer

Authors
  1. Laurence Desjardins-Crépeau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Louis Bherer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laurence Desjardins-Crépeau .

Editor information

Editors and Affiliations

  1. Faculty of Medicine, Université de Montréal, Montréal, Canada

    Hélène Girouard

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Desjardins-Crépeau, L., Bherer, L. (2016). Hypertension and Age-Related Cognitive Decline. In: Girouard, H. (eds) Hypertension and the Brain as an End-Organ Target. Springer, Cham. https://doi.org/10.1007/978-3-319-25616-0_2

Download citation

Publish with us

Policies and ethics

Search

Navigation